Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * patients of both genders (females and males) over 18 years of age * written informed consent obtained from the subjects prior to any procedures related to the study * understand all procedures to be applied within the scope of the study protocol * ambulatory patients with symptoms diagnosed with covid-19 with chest tomography (ct) result positivity in the last 72 hours * patients with stable clinical course and who could be treated on an ambulatory basis.

inclusion criteria: * patients of both genders (females and males) over 18 years of age * written informed consent obtained from the subjects prior to any procedures related to the study * understand all procedures to be applied within the scope of the study protocol * ambulatory patients with symptoms diagnosed with covid-19 with chest tomography (ct) result positivity in the last 72 hours * patients with stable clinical course and who could be treated on an ambulatory basis.

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: - patients of both genders (females and males) over 18 years of age - written informed consent obtained from the subjects prior to any procedures related to the study - understand all procedures to be applied within the scope of the study protocol - ambulatory patients with symptoms diagnosed with covid-19 with chest tomography (ct) result positivity in the last 72 hours - patients with stable clinical course and who could be treated on an ambulatory basis.

inclusion criteria: - patients of both genders (females and males) over 18 years of age - written informed consent obtained from the subjects prior to any procedures related to the study - understand all procedures to be applied within the scope of the study protocol - ambulatory patients with symptoms diagnosed with covid-19 with chest tomography (ct) result positivity in the last 72 hours - patients with stable clinical course and who could be treated on an ambulatory basis.